Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
King's College London
King's College London
European Institute of Oncology
Suzhou Genhouse Bio Co., Ltd.
Radboud University Medical Center
European Institute of Oncology
Guy's and St Thomas' NHS Foundation Trust
European Institute of Oncology
Mahidol University
University of Milan
University Medical Center Groningen
GCS Ramsay Santé pour l'Enseignement et la Recherche
Centre Leon Berard
West China Hospital
Ottawa Hospital Research Institute
Centre hospitalier de l'Université de Montréal (CHUM)
Regina Elena Cancer Institute
Kuwait Cancer Control Center
Sixth Affiliated Hospital, Sun Yat-sen University
Poitiers University Hospital
University Hospital, Ghent
University College, London
Guy's and St Thomas' NHS Foundation Trust
Sunnybrook Health Sciences Centre
Samsung Medical Center
Nanfang Hospital, Southern Medical University
National Cancer Institute, Naples
The Netherlands Cancer Institute
Rigshospitalet, Denmark
Centre Georges Francois Leclerc
Royal Marsden NHS Foundation Trust
Centre Leon Berard
Guy's and St Thomas' NHS Foundation Trust
Chang Gung Memorial Hospital
Chang Gung Memorial Hospital
Catholic University of the Sacred Heart
University Medical Center Groningen
Massachusetts General Hospital
Nanfang Hospital, Southern Medical University
Assiut University
Johann Wolfgang Goethe University Hospital
George Washington University
University Health Network, Toronto
Southern Tohoku BNCT Research Center
Universitätsklinikum Hamburg-Eppendorf
Erasmus Medical Center
Rigshospitalet, Denmark
Sunnybrook Health Sciences Centre
Universitaire Ziekenhuizen KU Leuven
The Christie NHS Foundation Trust
Federal University of Rio Grande do Sul